Last quarter (Q ), Health Sciences Group's total revenue was $4.94K, a decrease of -74.50% from the same quarter last year. In Q, Health Sciences Group's net income was $-1.04M. See Health Sciences Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 05	Dec 04	Dec 03	Dec 02	Dec 01
Total Revenue	$ 69.31K	$ 60.14K	$ 3.26M	$ 17.77M	$ 5.54M	$ 341.81K
Cost of Revenue	$ 51.57K	$ 37.23K	$ 2.85M	$ 15.49M	$ 4.05M	$ 258.82K
Gross Profit	$ 17.74K	$ 22.91K	$ 411.31K	$ 2.28M	$ 1.49M	$ 82.99K
Operating Expense	$ 2.44M	$ 7.51M	$ 5.46M	$ 7.83M	$ 5.57M	$ 908.46K
Operating Income	$ -2.43M	$ -7.48M	$ -5.05M	$ -5.55M	$ -4.08M	$ -825.47K
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	$ 2.32M	$ 2.98M	$ -1.10M	$ -793.13K	-	$ 94.82K
Pretax Income	$ -3.78M	$ -5.58M	$ -6.89M	$ -7.42M	$ -4.28M	$ 735.10K
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -4.05M	$ -6.09M	$ -10.95M	$ -8.45M	$ -4.28M	$ -735.10K
Basic EPS	$ -0.11	$ -0.25	$ -0.78	$ -0.76	$ -0.73	$ -0.22
Diluted EPS	$ -0.11	$ -0.25	$ -0.78	$ -0.76	$ -0.73	$ -0.22
Basic Average Shares	$ 131.74M	$ 24.56M	$ 14.13M	$ 11.10M	$ 5.84M	$ 3.29M
Diluted Average Shares	$ 131.74M	$ 24.56M	$ 16.30M	$ 12.42M	$ 5.84M	$ 3.29M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 2.50M	$ 7.54M	$ 8.31M	$ 23.32M	$ 9.62M	$ 1.17M
Net Income From Continuing And Discontinued Operation	$ -3.76M	$ -5.75M	$ -10.44M	$ -7.42M	$ -4.28M	$ -735.10K
Normalized Income	$ -6.06M	$ -8.55M	$ -5.80M	$ -6.63M	$ -4.28M	$ -735.10K
Interest Expense	-	-	-	-	-	-
EBIT	$ -2.43M	$ -7.48M	$ -5.05M	$ -5.55M	$ -4.08M	$ -825.47K
EBITDA	$ -220.47K	$ -4.97M	$ -3.46M	$ -4.07M	$ -3.78M	$ -792.57K

Currency in USD

Health Sciences Group Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing